BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

Catalyst Funds Management Pty Ltd's Holding History (CIK: 0001896150)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 24,900 Value ($000) $189 Avg Close $7.60 Range $6.17 - $8.88
Q2 2024
Shares 28,500 Value ($000) $176 Avg Close $5.52 Range $4.03 - $6.99